137 related articles for article (PubMed ID: 1391033)
1. Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals.
Etkin M; Filaccio M; Ellerson D; Suh SP; Claxton D; Gaozza E; Brenner M; Moen R; Belmont J; Moore KA
Hum Gene Ther; 1992 Apr; 3(2):137-45. PubMed ID: 1391033
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of retroviral transduction in chronic myelogenous leukemia.
Claxton D; Suh SP; Filaccio M; Ellerson D; Gaozza E; Andersson B; Brenner M; Reading C; Feinberg A; Moen R
Hum Gene Ther; 1991; 2(4):317-21. PubMed ID: 1665348
[TBL] [Abstract][Full Text] [Related]
3. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
4. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
5. Continuing immunoglobulin heavy chain gene rearrangements in chronic myeloid leukemia with recurrent B-lymphoid blast crises after bone marrow transplantation.
Kiyoi H; Fukutani H; Yamauchi T; Kubo K; Ohno R; Yamamori S; Naoe T
Leukemia; 1995 Feb; 9(2):265-70. PubMed ID: 7869762
[TBL] [Abstract][Full Text] [Related]
6. Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.
Nieborowska-Skórska M; Skórski T; Ratajczak MZ; Szczylik C; Malaguarnera L; Calabretta B
Folia Histochem Cytobiol; 1993; 31(4):161-7. PubMed ID: 8137996
[TBL] [Abstract][Full Text] [Related]
7. Retroviral mediated gene transfer in chronic myelogenous leukaemia.
Cornetta K; Moore A; Leemhuis T; Moen RC; Tricot G; Leibowitz D; Hoffman R
Br J Haematol; 1994 Jun; 87(2):308-16. PubMed ID: 7947272
[TBL] [Abstract][Full Text] [Related]
8. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
Skórski T; Szczylik C; Malaguarnera L; Calabretta B
Folia Histochem Cytobiol; 1991; 29(3):85-9. PubMed ID: 1794439
[TBL] [Abstract][Full Text] [Related]
9. [Marrow necrosis as the initial manifestation of a blast crisis in CML].
Guinea JM; Menchaca C; Pérez Clausell C; Aldamiz M
Sangre (Barc); 1992 Feb; 37(1):78-9. PubMed ID: 1585244
[No Abstract] [Full Text] [Related]
10. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene.
Hanania EG; Fu S; Zu Z; Hegewisch-Becker S; Korbling M; Hester J; Durett A; Andreeff M; Mechetner E; Holzmayer T
Gene Ther; 1995 Jun; 2(4):285-94. PubMed ID: 7552989
[TBL] [Abstract][Full Text] [Related]
11. Cell biology of CML--a model linking the chronic and terminal phases.
Gordon MY
Leuk Lymphoma; 1993; 11 Suppl 1():93-100. PubMed ID: 8251924
[TBL] [Abstract][Full Text] [Related]
12. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
13. [Immunophenotypes on blast cells of chronic myelogenous leukemia].
Motoji T
Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336
[TBL] [Abstract][Full Text] [Related]
14. [Expression of bcl-2 gene in the evolution of chronic myelogenous leukemia to blast crisis and its implication].
Sui X; Su L; Chu J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):27-9. PubMed ID: 11498840
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
Nguyen PL; Arthur DC; Litz CE; Brunning RD
Leukemia; 1994 Oct; 8(10):1654-62. PubMed ID: 7934161
[TBL] [Abstract][Full Text] [Related]
16. Chronic myeloid leukemia stem cells.
Jamieson CH
Hematology Am Soc Hematol Educ Program; 2008; ():436-42. PubMed ID: 19074122
[TBL] [Abstract][Full Text] [Related]
17. Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation.
Maher J; Colonna F; Baker D; Luzzatto L; Roberts I
Exp Hematol; 1994 Jan; 22(1):8-12. PubMed ID: 8282064
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation.
Rill DR; Buschle M; Foreman NK; Bartholomew C; Moen RC; Santana VM; Ihle JN; Brenner MK
Hum Gene Ther; 1992 Apr; 3(2):129-36. PubMed ID: 1391032
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cell kinetics and cell cycle status by treating CD34+ chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides.
Lanza F; Bi S; Moretti S; Castoldi G; Goldman JM
Br J Haematol; 1995 May; 90(1):8-14. PubMed ID: 7786800
[TBL] [Abstract][Full Text] [Related]
20. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
